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Abstract
Background: Although local excision (ampullectomy) was first described by Halsted in 1899, its
adequacy as an alternative surgical treatment for the ampullary tumors is still a matter of debate.
The aim of this study was to evaluate the results of ampullectomy as a curative treatment for benign
and malignant tumors arising from the ampulla, in a 14-year single-institution experience.
Methods: From 1990 to 2004, a total of 20 patients of adenocarcinoma (12) or adenoma (8) of
the ampulla of Vater underwent local excision. Clinical data were collected and morbidity,
mortality, as well as long-term survival were evaluated. The usefulness of several pre or
intraoperative diagnostic methods was also recorded. Median follow-up was 85 (range 6–180)
months.
Results: The combination of endoscopic preoperative biopsies and intraoperative frozen section
examination adequately diagnosed ampullary tumors in all cases. The postoperative morbidity and
mortality were 0%, whereas the 3 and 5-year survival rates for the patients with adenocarcinoma
was 75 % and 33.3 % respectively. All the patients with adenoma are still alive without any sign of
recurrence.
Conclusion: In our series, local excision was a safe option, associated with satisfactory long-term
survival rates in patients with benign lesions and in those with small(<2 cm), pT1, well differentiated
ampullary tumours without nodal involvement.
Background
Mass lesions of the ampulla of Vater represent less than
10% of pancreatic and periampullary tumors. Among
these, carcinomas, adenomas and neuroendocrine tumors
are the most frequently recognized neoplasms [1].
Since 1935, pancreatoduedectomy (PD) has been used as
the treatment of choice for the neoplasms arising from the
ampulla of Vater [2-4]. Although mortality rates have
been reduced nowadays, PD is still associated with high
morbidity rates [3,5-7]. In order to reduce PD associated
complications, local excision of the ampulla of Vater
(ampullectomy) has been introduced as an alternative
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procedure for selected cases [8]. Several suggestions have
been reported in order to define the criteria for ampullec-
tomy such as the tumor's stage, nodal involvement, differ-
entiation, as well as the patients' age and concomitant
illness [9,10]. Some authors suggest that all patients with
ampullary tumors, even benign ones, should undergo rad-
ical resection, citing problems such as a high incidence of
malignancy in ampullary villous tumors, difficulty in
excluding malignancy with preoperative biopsy, an
increased tendency for these lesions to recur after local
excision, as well as questions concerning its adequacy as a
cancer operation [11-13]. In contrast, other authors
believe that local resection is an acceptable form of treat-
ment with satisfactory survival rates in selected patients
and markedly decreased morbidity and mortality rates
compared with radical resections [10,14,15].
We present our experience with patients who underwent
local excision of ampullary tumours. Indications, surgical
technique, outcome, and long-term results are discussed
with the purpose of drawing attention to the procedure as
a possible curative treatment for selected ampullary
tumours.
Methods
From 1990 to 2004, 20 patients suffering from ampullary
tumors were treated in our Department with local exci-
sion. Twelve (60%) patients were men and 8 (40%)
women with mean age 68.5 years (range: 47–79 years).
Twelve (60%) patients had carcinomas and eight (40%)
had adenomas. Only lesions confined to the ampulla or
clearly invading the surroundings tissues from the
ampulla, were designated as ampullary carcinomas.
The patients presented with obstructive jaundice, upper
abdominal pain, weight loss, nausea, vomiting, pancreati-
tis, and pruritus either as a single symptom or in combi-
nation. The preoperative diagnostic evaluation included
estimation of liver function tests (LFTs) and plasma amy-
lase levels, and standard imaging investigations which
included conventional ultrasonography (US) scan, com-
puted tomography (CT) scan and endoscopic retrograde
cholangiopangreaticography (ERCP) with multiple biop-
sies taken from the ampulla of Vater. During operation,
resection margins were evaluated by frozen section. No
patient in the study received adjuvant chemotherapy or
radiotherapy.
All the patients who pre or intraoperatively were diag-
nosed as carcinoma were considered suitable for ampul-
lectomy according to the following criteria: 1) lesion less
than 2 cm in diameter, 2) pT1 cancer 3) well or moderate
differentiated tumors without nodal involvement.
Besides, local excision was the preferable treatment when
the patient's concomitant medical illness or age contrain-
dicated a major operation such as PD. All pre or intraop-
eratively diagnosed benign lesions were considered
suitable for ampullectomy, as well. If preoperative ERCP
revealed involvement of the distal bile duct or pancreatic
duct greater than 1 cm, a PD was considered rather than a
local excision.
All patients underwent regular 3 monthly follow-up
examinations for the first year, on a 6-month basis for the
following 4 years and annually thereafter. Follow-up
included clinical examination, blood tests (CA 19-9, LFT),
abdominal ultrasound, and chest radiography. Duode-
noscopy and ERCP were performed at 6 monthly intervals
for two years and then once a year, and earlier if the
patient had symptoms.
Local resection technique
The abdomen was explored through a subcostal or mid-
line incision. After a Kocher maneuver for the mobiliza-
tion of the second part of the duodenum, the latter was
opened by a 4–5 cm "antimesenteric" longitudinal inci-
sion. Stay sutures were placed in the duodenal wall cir-
cumferentially, and bile and pancreatic duct were
canulated with a Fogarty catheter. Then, the normal duo-
denal mucosa surrounding the ampullary tumor was
injected with saline containing 1 to 100,000 epinephrine.
Once the identification of the ducts had been accom-
plished, a circumferential resection of duodenal mucosa
to a depth necessary to excise the tumor was undertaken.
Margins of 1 cm were obtained in all directions beyond
the gross border of the lesion, in order to obtain free mar-
gins resection. Frozen section from the tumor and the sur-
rounding tissues was performed to confirm or not tumor's
malignancy and to ensure negative margins respectively.
Besides, a routine lymph node dissection was performed
in patients with ampullary cancer before local excision,
which included the supraduodenal as well as anterior and
posterior lymph nodes of the pancreatic head. The speci-
mens were also sent for frozen section. If the pathological
results did not meet the criteria for a potential curative
local resection (pT1 stage, well differentiation, negative
lymph nodes) a PD operation was considered, if medi-
cally fit, otherwise the ampullectomy was continued.
Because bile and pancreatic ducts were transected a recon-
struction procedure was essential to ensure adequate bil-
liary and pancreatic drainage and to repair the
transduodenal defect. Reconstruction was accomplished
by approximating the common walls of the pancreatic
and bile ducts that eventually were sutured together on
the duodenal wall. Thereafter, the ducts were probed with
billiary dilators to ensure appropriate size. A diameter of
6 to 8 mm for the bile duct and 4 to 5 mm for the pancre-
atic duct were obtained, assuming that scarring will
reduce these diameters by 50%. After the establishment ofWorld Journal of Surgical Oncology 2006, 4:14 http://www.wjso.com/content/4/1/14
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an adequate duct patency the duodenotomy was closed
transversely.
Results
All 20 patients were clinically symptomatic at the time of
surgery. The most common symptom for those with ade-
noma was abdominal pain (68%), whereas nausea and
vomiting were second in frequency (38%). Acute pancre-
atitis was present in 1 of 8 patients with benign lesions.
Obstructive jaundice (69%) was the most common pre-
senting symptom among those with malignancy. Abdom-
inal pain (47%), weight loss (38%), and pruritus (30%)
were also common. Jaundice and pruritus were more
prevalent in those with carcinoma, whereas pancreatitis
was more common in patients with benign lesions. The
median time of the patients' symptoms was 8 weeks in the
adenoma group and 5 weeks among the patients with
malignancy.
All the patients of the study underwent preoperative (US)
scan, (CT) scan and ERCP with multiple biopsies taken
from the suspicious area. ERCP showed that in 14 patients
the tumor was localized in the ampulla, whereas in
remaining 6 was hidden juts behind the orifice of the
ampulla. Duodenoscopy with biopsies failed to reveal
malignancy in 10% of the patients. Two of the patients
with benign preoperative biopsies had adenocarcinoma
detected at the time of the frozen section, which was fur-
ther confirmed by the final pathologic analysis. In addi-
tion to preoperative biopsy all the patients had frozen
section (FSE) analysis of the operative specimen. FSE
accurately predicted the final histology in all patients. The
combination of preoperative and frozen section biopsies
was 100% accurate for the diagnosis of adenoma or aden-
ocarcinoma. In none of the patients of our study, surgical
margins were found to be positive by frozen section exam-
ination. Besides, in all cases, negative frozen sections were
also negative for malignancy in the final pathological
report, as well.
The median size of the tumors, as measured by the pathol-
ogist, was 1.3 cm (range: 0.7–1.8). The carcinomas were
classified as pT1 with well or moderate differentiation (G1
or G2) in 10 patients with malignancy, and as pT2 tumors
with moderate and low differentiation in the remaining
two. There was no lymph node metastasis in any of these
patients. PD was considered for the two patients with pT2
tumors. However, concomitant defects such as pulmo-
nary, cardiac and vascular disease precluded safe perform-
ance of the PD.
In the early postoperative period, there were no in hospi-
tal deaths or any major postoperative complication asso-
ciated with the procedure. Only two minor complications
were recorded, one wound infection and one case of post-
operative pneumonia.
Median follow up was 85 (6–180) months. During fol-
low-up period, all patients with adenoma are alive with-
out any sign of tumor recurrence. Follow-up was closed
for each patient with ampullary carcinoma after a follow-
up period of five years unless death occurred during this
time. Five patients have died during follow-up and all but
two died because of recurrence. Three patients that died
due to recurrence include the patients (n = 2) with pT2
carcinomas. Finally, 3 patients are alive at 6 months, 3
and 4 years after the operation respectively. Following
local excision of the ampullary cancer in 12 patients, the
survival rate at 3 years was 75% (9 patients) and 33.3% (4
patients) at 5 years. In the patients with ampullary cancer
that achieved 5-year survival, the resection was R0, the
tumor was graded as pT1, N0, M0 and, moreover, it was
well differentiated. The probability of survival is shown in
figure 1. The median hospital stay was 8 (7–10) days.
Discussion
Neoplasms of the ampulla of Vater belong to the group of
periampullary tumors, which also includes tumors origi-
nating from the pancreas, the common bile duct or the
duodenum [16,17]. The benign tumors of the ampulla are
rare. Among these the most common recognized is ade-
noma [18], whereas the other benign types (lipomas, neu-
romas, etc.) are very unusual [19]. Malignant tumors of
the ampulla are also rare and adenocarcinoma represents
the most common pathological variety. Adenomatous tis-
Time to death for patients who underwent local excision  (Kaplan – Meier statisticall analysis) Figure 1
Time to death for patients who underwent local excision 
(Kaplan – Meier statisticall analysis). The 3 and 5-year survival 
rates for the patients with adenocarcinoma was 75% and 
33,3% respectively.World Journal of Surgical Oncology 2006, 4:14 http://www.wjso.com/content/4/1/14
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sue is found in 80% of the adenocarcinomas [20], suggest-
ing that the malignant tumors arise from adenomas.
According to this observation, there is little argument over
the necessity of adenomas resection, while there is no
doubt regarding the resection of malignant tumors, if it is
possible.
Controversy exists over how to manage these lesions. Pan-
creaticoduedenectomy is the standard surgical treatment
[2-4], however alternative techniques such as local
[8,10,14,15] or endoscopic resection [21], have been also
used. In this study, we present our experience on the treat-
ment of benign or malignant lesions of the ampulla using
local resection. In our Unit, endoscopic excision was not
used due to lack of relevant experience.
The accurate diagnosis and characterization of the ampul-
lary tumors is, undoubtedly, essential, in order to select
the appropriate patients for a potentially curative local
resection. Conventional techniques, such as ultrasonogra-
phy and computed tomography (CT), have been used for
this reason, but they have been not found sensitive
enough in detecting ampullary lesions and, therefore,
should not be relied upon for initial diagnosis [22]. There
are studies reporting that CT detects the lesion in only
20% of patients [11,22]. However, these methods may
offer useful information that would add to the diagnosis
and characterization of the tumor. In particular, the dila-
tation of the pancreatic or common bile duct can be seen
in ultrasonography, whereas CT is able to detect meta-
static tumors. In three patients of our study the common
bile duct was found dilated, whereas none of twelve
patients with adenocarcinoma presented with metastatic
disease.
The diagnosis of an ampullary tumor may be made by
direct visualization using ERCP. ERCP is also helpful in
identifying the extent, size, and gross appearance of the
tumor, whereas gives the ability of taking endoscopic pre-
operative biopsies. These biopsies are considered the pri-
mary mean for the histological characterization of the
lesions. However, they have a variable rate of accuracy,
although the fact that the region of the ampulla is easily
accessible for such interventions. Some authors have
reported false negative biopsies, ranging from 25% to
60% [14,23,24], whereas others have found remarkably
lower rates such as 11,7% [25]. These conflicted results
led to a consensus that malignancy cannot be reliably
excluded based on endoscopic biopsy alone. In our series,
endoscopic preoperative biopsy showed similar lack of
accuracy, as it failed to detect the malignancy in 17% of
cases. However, this diagnostic problem can be amelio-
rated with the use of frozen section analysis intraopera-
tively. It has been suggested that FSE is a useful adjunct in
distinguishing adenoma from adenocarcinoma, predict-
ing accurately the final histology in all patients [25]. A
recent study, reported sensitivity of 85% and specificity of
100% for intraoperative frozen section biopsy, concern-
ing adenocarcinoma [25]. Furthermore, frozen section
examination of the resection margin during ampullec-
tomy may help to obtain a free resection margin. In our
patients, FSE accurately predicted the final histology in all
cases, while the combination of preoperative and frozen
section biopsies was 100% accurate for the diagnosis of
adenoma or adenocarcinoma, which is in accordance
with findings reported by other authors [1]. In addition to
ERCP biopsies and FSE, another useful adjunct for the pre-
operative planning is Endoscopic ultrasound (EUS)
[10,22]. EUS cannot replace histological evaluation, and
thus, a differentiation between an adenoma and a pT1 car-
cinoma is not possible. However, EUS may be extremely
useful as the most accurate method to determine tumor
stage and select patients for local excision. It is stated that
EUS can easily differentiate a grossly infiltrating tumor
from an early cancinoma [10]. EUS is also reported to
delineate clearly the layered structures of the duodenal
wall in the ampullary region and to diagnose accurately
the presence and extent of tumor invasion into duode-
num or common bile duct wall and the involvement of
the pancreas [22]. Underestimating the depth of invasion
occurs rarely while over staging is reported to occur in one
third of pT1 tumors [10]. EUS was not included in our
diagnostic tools due to lack of experience and relevant
equipment. It seems that EUS might have been very help-
ful in preoperative identification of the patients who met
the criteria for local excision in our study.
Based on these diagnostic procedures, 8 out of 20 patients
in our series were proved to have an adenoma, while the
remaining had an adenocarcinoma. In all these patients, a
local resection technique was applied. In benign lesions,
there are many reports suggesting that local excision is an
inadequate treatment, stating problems, such as a high
incidence of malignancy in benign ampullary tumors and
an increased tendency of these lesions to recur after local
resection [11-13]. Galandiuk et al [23], reported a local
recurrence rate of 42% among 13 patients who underwent
local excision for villous tumors. In a more recent study,
Farnell et al [26] found a recurrence rate of 32% at 5-years
and 43% at 10 years in 53 patients with villous tumors,
who underwent transduodenal submucosal resection.
This high rate of recurrence was attributed to narrow mar-
gins for lesions close to the ampulla, which resulted to
inadequate free margin resection. On the other hand, pro-
ponents of local resection emphasize the importance of
obtaining adequate margins and report low recurrence
rates [10,14,15]. Rattner et al [10], reported no local recur-
rences at a mean follow-up of 29 months, including two
patients with invasive carcinoma. In a recent study, 17 out
of 18 patients with benign lesions remained disease freeWorld Journal of Surgical Oncology 2006, 4:14 http://www.wjso.com/content/4/1/14
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for a mean follow-up time of 38 months [27]. Most stud-
ies cite low rates of recurrence for benign adenomas, rang-
ing from 11% to 33% [10,13-15,23]. In our series, after a
median follow-up of 85 months all patients with ade-
noma are alive without any sign of tumor recurrence.
Although there are many case reports and a few series on
the treatment of ampullary malignancies by local ampul-
lary excision, the criteria used to decide when local exci-
sion is suitable for patients with adenocarcinoma are
controversial, and not well addressed. We performed local
resection to patients with small (less than 2 cm), pT1
tumors, well or moderate differentiated carcinomas, as
well as in cases with advanced adenocarcinomas (pT2),
which were unfit for PD, due to concomitant illness. There
was no lymph node metastasis in any of these patients. To
achieve operative curability with ampullectomy, two crite-
ria seem that should be fulfilled: no lymph node metasta-
sis and a free resection margin. As we mentioned before, a
free margin resection can be achieved in most cases by an
adequate local resection technique, in combination with
intraoperative biopsies. On the other hand, lymph node
metastasis, perineural invasion and lymphovascular inva-
sion have been identified as important factors affecting
the survival and the recurrence after local resection [28].
Therefore, the selection of ampullary cancers without
lymph node metastasis preoperatively is essential for a
curative local resection. However, preoperative imaging
modalities have limitations in terms of diagnosing
regional lymph node metastasis and even EUS has been
found to be inadequate to predict accurately the presence
or absence of lymph node metastasis [29,30]. Thus, it
became essential to identify clinicopathologic factors able
to predict lymph node metastasis before operation. Bott-
ger and Junginger [5] reported that lymph node metastasis
were not found in small, or T1 tumors, or in tumors with
well differentiated histology. Similar results have been
also reported from other authors [9,28,30,31]. Rattner et
al [10], recommended ampullectomy for T1 cancer, and
Beger et al [14] for Tis or T1, N0, M0 cancer with well or
moderate differentiation. These findings suggest that
small tumors, staging as Tis or T1 with well differentia-
tion, appears to be an essential condition for local resec-
tion.
Although the fact that the vast majority of the ampullec-
tomy studies include limited number of patients, their
results in regard to morbidity, mortality and long term
survival are encouraging and thus, cannot be ignored. Rat-
tner et al [10], reported nil morbidity and mortality rates
after local resection, while other authors, found mortality
rates ranging from 0% to 25% [32-36]. Similar results
were also reproduced in our study. We had nil morbidity
and mortality rates after ampullectomy, even in the group
with adenocarcinoma patients. Attempting to explain
these rates we must underlie the advantages of local resec-
tion as surgical technique. Local resection is a simple tech-
nique, which can be performed safely, requiring
significantly less time and with decreased blood loss. This
is translated into a decrease in the number of patients
requiring perioperative blood transfusions. Blood transfu-
sion has been reported to be related with poor prognosis
in patients undergoing resection for ampullary cancer
[28]. Additionally, the in-hospital length of stay after
ampullectomy is relatively low (10 days) [10,25], leading
to a decreased chance of developing complications result-
ing from hospitalization. In regard to long-term survival
the results are encouranging. Shutze et al [37], reviewed
15 series totalling 520 patients with a combined survival
of 40%. Six other series totalling 68 patients report a 5-
year survival rate of 40% [1,33-35,38,39]. In our study,
which included a small number of patients, following
local excision of the ampullary cancer, the survival rate at
3 and 5 years was 75% and 33,3% respectively.
Conclusion
In our series, local excision was a safe option, associated
with satisfactory long-term survival rates in patients with
benign lesions and in those with malignant ones, who
had small (<2 cm), pT1, well differentiated ampullary
tumours without nodal involvement.
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